INTERNATIONAL PATENT: GC GENOME CORPORATION, 주식회사 지씨지놈 FILES APPLICATION FOR "DNA METHYLATION MARKER FOR PREDICTING RESPONSIVENESS TO RADIOTHERAPY FOR ESOPHAGEAL CANCER AND GASTRIC CANCER AND USES THEREOF"

GENEVA, June 11 -- GC GENOME CORPORATION (107, Ihyeon-ro 30beon-gil, Giheung-guYongin-siGyeonggi-do 16924), 주식회사 지씨지놈 (경기도용인시기흥구 이현로30번길 107) filed a patent application (PCT/KR2024/019135) for "DNA METHYLATION MARKER FOR PREDICTING RESPONSIVENESS TO RADIOTHERAPY FOR ESOPHAGEAL CANCER AND GASTRIC CANCER, AND USES THEREOF" on Nov 28, 2024. With publication no. WO/2025/116563, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intel...